Cristina Solé | Biochemistry, Genetics and Molecular Biology | Women Researcher Award

Published on by Global Scholar Awards

Dr. Cristina Solé | Biochemistry, Genetics and Molecular Biology | Women Researcher Award

Investigadora Principal Sénior-Júnior at Vall Hebron Institut Research VHIR, Spain

Dr. Cristina Solé Marcé is a distinguished researcher specializing in systemic lupus erythematosus (SLE) with over a decade of experience in clinical-translational research. She holds dual degrees in Chemistry and Biochemistry, a PhD with international distinction, and a master’s in Synthesis and Catalysis from Universitat Rovira i Virgili. As a Senior-Junior Principal Investigator at Vall d’Hebron Research Institute, her work focuses on identifying novel biomarkers, developing personalized treatments, and exploring innovative therapies such as CAAR-T cells for lupus nephritis. She has published 31 scientific articles, with 94% as first, last, or corresponding author, and has collaborated with leading institutions, startups, and pharmaceutical companies. A recipient of the 2023 Health Science Award from the Institut d’Estudis Catalans, she is actively engaged in clinical trials, mentorship, and public science outreach. Dr. Solé’s contributions significantly advance lupus research, making her an outstanding candidate for the Women Researcher Award.

Professional Profile 

Education

Dr. Cristina Solé Marcé has a strong academic background in chemistry, biochemistry, and translational medicine. She earned dual degrees in Chemistry and Biochemistry from Universitat Rovira i Virgili, followed by a master’s in Synthesis and Catalysis at the same institution. She later pursued a PhD with international distinction, focusing on innovative research in systemic lupus erythematosus (SLE). Her doctoral work provided a solid foundation for her career in clinical and translational research, particularly in autoimmune diseases. Committed to continuous learning, Dr. Solé has engaged in specialized training programs, including those in biomarker discovery and personalized medicine. Her educational journey, complemented by interdisciplinary expertise and hands-on research, has positioned her as a leading scientist in lupus research. With extensive collaborations and contributions to high-impact publications, her academic achievements continue to shape advancements in precision medicine and novel therapeutic approaches for lupus and related autoimmune disorders.

Professional Experience

Dr. Cristina Solé Marcé is an accomplished researcher specializing in autoimmune diseases, particularly systemic lupus erythematosus (SLE). She has extensive experience in translational and clinical research, focusing on biomarker discovery and personalized medicine. Throughout her career, she has collaborated with leading research institutions and hospitals, contributing to the advancement of novel diagnostic and therapeutic strategies. Dr. Solé has played a key role in multidisciplinary research projects, integrating molecular biology, immunology, and clinical data to improve patient outcomes. She has also published extensively in high-impact scientific journals and presented her findings at international conferences. Her expertise extends to project management, mentorship of young researchers, and securing competitive research funding. Currently, she continues to drive innovation in lupus research, leveraging her knowledge in precision medicine to develop targeted treatments. Her work has had a significant impact on improving the understanding and management of autoimmune diseases worldwide.

Research Interest

Dr. Cristina Solé Marcé’s research interests focus on autoimmune diseases, with a particular emphasis on systemic lupus erythematosus (SLE). Her work explores the molecular mechanisms underlying disease pathogenesis, aiming to identify novel biomarkers for early diagnosis, prognosis, and treatment response. She is deeply involved in translational research, integrating clinical data with advanced molecular and immunological techniques to develop personalized therapeutic strategies. Dr. Solé is particularly interested in the role of epigenetics, gene expression, and immune system dysregulation in lupus and related disorders. Her research also extends to precision medicine approaches, seeking to tailor treatments to individual patients based on their genetic and molecular profiles. She collaborates with multidisciplinary teams, including clinicians, bioinformaticians, and immunologists, to translate laboratory discoveries into clinical applications. Through her work, Dr. Solé aims to enhance disease management and improve the quality of life for patients suffering from autoimmune conditions.

Award and Honor

​Dr. Cristina Solé Marcé is a distinguished researcher specializing in autoimmune diseases, particularly systemic lupus erythematosus (SLE) and antiphospholipid syndrome. Since 2021, she has served as a Senior-Junior Principal Investigator in the Rheumatology team at the Systemic Lupus Erythematosus Unit of the Vall Hebron Research Institute (VHIR). Prior to this role, she dedicated six years as a postdoctoral researcher within the same unit. Her research endeavors focus on enhancing patient outcomes by identifying novel biomarkers to monitor disease status non-invasively and exploring the effects of new drugs and molecular pathways involved in various clinical manifestations. This work has led to multiple publications in internationally recognized journals and invitations to present at prestigious conferences such as the American College of Rheumatology (ACR) and the European Alliance of Associations for Rheumatology (EULAR).

Research Skill

Dr. Cristina Solé Marcé possesses a diverse range of research skills, particularly in the fields of autoimmune diseases, biomarker discovery, and drug synthesis. She has extensive experience in molecular biology techniques, biochemical assays, and analytical chemistry, which she applies to her studies on systemic lupus erythematosus (SLE) and antiphospholipid syndrome. Her expertise includes non-invasive biomarker identification to improve disease monitoring and understanding the mechanisms of action of novel therapeutic agents. With a strong background in synthetic chemistry, she has worked on the enantioselective synthesis of drugs and the development of anticancer compounds. Additionally, she is skilled in experimental design, data analysis, and scientific communication, with multiple publications in high-impact journals and presentations at international conferences such as ACR and EULAR. Her interdisciplinary approach, combining chemistry, biochemistry, and immunology, enables her to contribute significantly to translational research and patient-centered advancements in rheumatology.

Conclusion

Dr. Cristina Solé Marcé is a highly accomplished researcher with an impressive track record in autoimmune disease research, particularly lupus. Her combination of scientific excellence, leadership, international collaboration, and patient engagement makes her a compelling candidate for the Women Researcher Award. Strengthening her funding profile and expanding her research applications could further solidify her impact. Given her current achievements, she is well-deserving of recognition through this award.

Publications Top Noted

  • Solé et al., 2025 – Topical miRNA Delivery via Elastic Liposomal Formulation: A Promising Genetic Therapy for Cutaneous Lupus Erythematosus. Int. J. Mol. Sci. DOI: 10.3390/ijms26062641
  • Sandoval, Solé et al., 2024 – Neuropilin-1 as a Key Molecule for Renal Recovery in Lupus Nephritis: Insights from an NZB/W F1 Mouse Model. Int. J. Mol. Sci. DOI: 10.3390/ijms252111364
  • Solé et al., 2024 – Precise Targeting of Autoantigen-Specific B Cells in Lupus Nephritis with Chimeric Autoantibody Receptor T Cells. Int. J. Mol. Sci. DOI: 10.3390/ijms25084226
  • Solé et al., 2023 – Small-Extracellular-Vesicle-Derived miRNA Profile Identifies miR-483-3p and miR-326 as Regulators in the Pathogenesis of Antiphospholipid Syndrome (APS). Int. J. Mol. Sci. DOI: 10.3390/ijms241411607
  • Solé et al., 2023 – Downregulation of miR-885-5p Promotes NF-κB Pathway Activation and Immune Recruitment in Cutaneous Lupus Erythematosus. J. Investig. Dermatol. DOI: 10.1016/j.jid.2022.08.036
  • Solé et al., 2022 – Humoral and Cellular Response in Convalescent COVID-19 Lupus Patients. Sci. Rep. DOI: 10.1038/s41598-022-17334-5
  • Domingo, Solé et al., 2021 – Thalidomide Exerts Anti-Inflammatory Effects in Cutaneous Lupus by Inhibiting the IRF4/NF-ҡB and AMPK1/mTOR Pathways. Biomedicines. DOI: 10.3390/biomedicines9121857
  • Domingo, Solé et al., 2020 – Efficacy of Thalidomide in Discoid Lupus Erythematosus: Insights into the Molecular Mechanisms. Dermatology. DOI: 10.1159/000508672
  • Domingo, Solé et al., 2020 – MicroRNAs in Several Cutaneous Autoimmune Diseases: Psoriasis, Cutaneous Lupus Erythematosus, and Atopic Dermatitis. Cells. DOI: 10.3390/cells9122656
  • Garcia-Vives, Solé et al., 2020 – The Urinary Exosomal miRNA Expression Profile is Predictive of Clinical Response in Lupus Nephritis. Int. J. Mol. Sci. DOI: 10.3390/ijms21041372
  • Solé et al., 2019 – MicroRNA Expression Profiling Identifies miR-31 and miR-485-3p as Regulators in the Pathogenesis of Discoid Cutaneous Lupus. J. Investig. Dermatol. DOI: 10.1016/j.jid.2018.07.026

Javier Ventura-Juárez | Biochemistry | Best Researcher Award

Published on by Global Scholar Awards

Dr. Javier Ventura-Juárez | Biochemistry | Best Researcher Award

Jefe de laboratorio de Ciencias Morfológicas at Universidad Autónoma de Aguascalientes, Mexico

Dr. Javier Ventura-Juárez is a highly regarded academic and researcher with a significant career spanning over four decades. Currently a Profesor Investigador Titular “C” at the Universidad Autónoma de Aguascalientes (UAA) in the Department of Morphology, he has greatly contributed to both education and scientific research. Known for his expertise in morphology and pathology, Dr. Ventura-Juárez is a distinguished member of the Mexican National System of Researchers (SNI), where he holds Level III status—one of the highest acknowledgments in Mexican research. His scholarly output includes numerous peer-reviewed articles, book chapters, and participation in conferences worldwide. Over the years, he has also mentored a vast number of students, fostering the next generation of scientists and healthcare professionals. His career reflects both depth and breadth across education, mentorship, research, and academic leadership, earning him recognition and numerous prestigious awards within the scientific community.

Professional Profile

Education

Dr. Ventura-Juárez has a robust academic foundation, beginning with his Licenciatura (M.D. equivalent) as a Médico Cirujano y Partero from the Escuela Superior de Medicina at Instituto Politécnico Nacional (IPN), completed in 1976. He then pursued a Master’s degree in Sciences with a specialization in Morphology from IPN, earning his degree in 1987. His master’s thesis involved immunoenzyme identification and functional characterization of lymphocytes with histamine receptors in rat intestinal mucosa. Building on this specialization, he completed his Ph.D. in Experimental Pathology at the Centro de Investigación y Estudios Avanzados of IPN in 1997. His doctoral research explored endothelial cell interaction and activation by antigens from Entamoeba histolytica in liver parenchyma, reflecting his deep commitment to understanding complex interactions in pathology. This progressive academic journey laid a strong foundation for his research in morphology and pathology.

 

Professional Experience

Since January 2000, Dr. Ventura-Juárez has served as a Profesor Investigador Titular “C” in the Department of Morphology at UAA, where he works on morphology and pathology education and research. Prior to this role, he taught over 300 undergraduate courses in histology, embryology, and anatomy at the Interdisciplinary Center for Health Sciences of IPN from 1977 to 1999. Since joining UAA, he has taught 64 courses in anatomy and histology and 33 postgraduate morphology courses in UAA’s Basic Sciences Center. As an invited evaluator for CONACYT and PRODEP, he has also contributed his expertise to national research standards. Dr. Ventura-Juárez’s professional career is distinguished not only by his teaching excellence but also by his research project leadership, with involvement in numerous CONACYT-supported projects and registered research initiatives within UAA.

Research Interest

Dr. Ventura-Juárez’s primary research interests lie in morphology, pathology, and immunology, focusing on the cellular and molecular dynamics within tissue and immune responses. His work initially centered on immunological interactions in morphology, as seen in his Master’s thesis on lymphocyte receptors in rat intestinal mucosa. His doctoral research further expanded these interests by studying the interactions between liver endothelial cells and inflammatory cells in response to antigens from Entamoeba histolytica, contributing valuable insights into host-pathogen interactions and tissue pathology. Over his career, he has led several CONACYT-funded research projects and contributed to 19 institutional projects registered with UAA. His publications, which include peer-reviewed articles in national and international journals and seven book chapters, reflect his commitment to advancing knowledge in morphology and pathology, as well as his interest in disseminating his findings to a wider scientific audience.

Award and Honor

Dr. Ventura-Juárez has received numerous awards and honors that highlight his exceptional contributions to research and education. He has been a member of Mexico’s National System of Researchers (SNI) since 1998 and currently holds the esteemed Level III status, valid through 2026, recognizing his significant scientific achievements. Within UAA, he has twice received the Premio Universitario al Mérito en Investigación: in 2007 as an advanced researcher and in 2023 as a consolidated researcher. His mentorship has also been recognized, as he has supervised several award-winning doctoral theses in 2011, 2015, and 2023. With an ongoing desirable research profile under the PRODEP program through 2025, Dr. Ventura-Juárez’s awards and honors reflect his influence as a mentor, researcher, and leader in advancing morphological and pathological sciences.

Conclusion

Dr. Javier Ventura Juárez is a well-qualified candidate for the Best Researcher Award. His extensive contributions to research, education, and mentorship, coupled with a strong record of national and international publications and conference presentations, underscore his value as an advanced and established researcher. His influence on student research and his recognized leadership in research evaluation further solidify his reputation in the field. Continued expansion into high-impact publications and international collaborations would enhance his already impressive profile, making him a deserving candidate for this prestigious award.

Publications top noted

  • Title: Amoebicidal Activity of Essential Oil of Dysphania ambrosioides (L.) Mosyakin & Clemants in an Amoebic Liver Abscess Hamster Model
    Authors: ME Ávila-Blanco, MG Rodríguez, JL Moreno Duque, M Muñoz-Ortega, J Ventura-Juárez
    Year: 2014
    Citation Points: 53
  • Title: Clinical Case of Cerebral Amebiasis Caused by E. histolytica
    Authors: CA Maldonado-Barrera, MR Campos-Esparza, L Muñoz-Fernández, J Ventura-Juárez
    Year: 2012
    Citation Points: 52
  • Title: Entamoeba histolytica Contains a β1 Integrin-like Molecule Similar to Fibronectin Receptors from Eukaryotic Cells
    Authors: P Talamás-Rohana, VI Hernández-Ramirez, JN Perez-García, J Ventura-Juárez
    Year: 1998
    Citation Points: 50
  • Title: Early Interactions of Entamoeba histolytica Trophozoites with Parenchymal and Inflammatory Cells in the Hamster Liver: An Immunocytochemical Study
    Authors: J Ventura-Juárez, R Campos-Rodríguez, V Tsutsumi
    Year: 2002
    Citation Points: 46
  • Title: Human Amoebic Hepatic Abscess: In Situ Interactions Between Trophozoites, Macrophages, Neutrophils, and T Cells
    Authors: J Ventura-Juárez, RA Jarillo-Luna, E Fuentes-Aguilar, V Tsutsumi
    Year: 2003
    Citation Points: 42
  • Title: Hypophysectomy and Neurointermediate Pituitary Lobectomy Reduce Serum Immunoglobulin M (IgM) and IgG and Intestinal IgA Responses to Salmonella enterica Serovar Typhimurium
    Authors: R Campos-Rodríguez, A Quintanar-Stephano, RA Jarillo-Luna, J Ventura-Juárez
    Year: 2006
    Citation Points: 36
  • Title: Therapeutic Perspectives of p-Coumaric Acid: Anti-necrotic, Anti-cholestatic, and Anti-amoebic Activities
    Authors: LR Aldaba-Muruato, J Ventura-Juárez, AM Perez-Hernandez
    Year: 2021
    Citation Points: 35
  • Title: A Review of the Proposed Role of Neutrophils in Rodent Amebic Liver Abscess Models
    Authors: R Campos-Rodríguez, M Gutiérrez-Meza, RA Jarillo-Luna, J Ventura-Juárez
    Year: 2016
    Citation Points: 35
  • Title: Precision-cut Hamster Liver Slices as an Ex Vivo Model to Study Amebic Liver Abscess
    Authors: P Carranza-Rosales, MG Santiago-Mauricio, NE Guzmán-Delgado, J Ventura-Juárez
    Year: 2010
    Citation Points: 34
  • Title: Glycomacropeptide Attenuates Inflammation, Pruritus, and Th2 Response Associated with Atopic Dermatitis Induced by 2,4-Dinitrochlorobenzene in Rat
    Authors: FC Muñoz, MM Cervantes, D Cervantes-García, M Jiménez, J Ventura-Juárez
    Year: 2017
    Citation Points: 32
  • Title: Autofluorescence as a Tool to Study Mucus Secretion in Eisenia foetida
    Authors: RMG Heredia, RB Dueñas, S Castillo, J Ventura-Juárez, M Silva Briano, R Posadas
    Year: 2008
    Citation Points: 31
  • Title: Entamoeba histolytica: Production of Nitric Oxide and In Situ Activity of NADPH Diaphorase in Amebic Liver Abscess of Hamsters
    Authors: J Pacheco-Yepez, R Campos-Rodriguez, M Shibayama, J Ventura-Juárez
    Year: 2001
    Citation Points: 29
  • Title: Curcumin and α/β-Adrenergic Antagonists Cotreatment Reverse Liver Cirrhosis in Hamsters: Participation of Nrf-2 and NF-κB
    Authors: JR Macías-Pérez, BJ Vázquez-López, MH Muñoz-Ortega, J Ventura-Juárez
    Year: 2019
    Citation Points: 28
  • Title: Entamoeba histolytica Induces Human Neutrophils to Form NETs
    Authors: J Ventura-Juárez, MR Campos-Esparza, J Pacheco-Yepez, V Tsutsumi
    Year: 2016
    Citation Points: 28
  • Title: Expression of Immune Modulator Cytokines in Human Fulminant Amoebic Colitis
    Authors: RE Sierra-Puente, R Campos-Rodríguez, RA Jarillo-Luna, J Ventura-Juárez
    Year: 2009
    Citation Points: 28

Hsin-Hou Chang | Biochemistry | Best Researcher Award

Published on by Global Scholar Awards

Prof. Dr. Hsin-Hou Chang | Biochemistry | Best Researcher Award

Professor at Tzu Chi University, Taiwan

Prof. Dr. Hsin-Hou Chang is a distinguished molecular biologist and professor at Tzu-Chi University, Taiwan, with a career spanning over two decades. He earned his Ph.D. from National Yang-Ming University in 1996 and has since held prominent roles, including Chair of the Department of Molecular Biology and Human Genetics and Dean of the College of Life Sciences at Tzu-Chi University. Dr. Chang’s research explores crucial biomedical areas such as immune responses, inflammation, cellular stress, and therapeutic drug delivery. His impressive portfolio includes 64 publications in high-impact journals, addressing critical issues like gastrointestinal injury, liver damage, and cellular death pathways, with significant implications for treatment and healthcare. Known for his collaborative research style, Dr. Chang has worked with numerous interdisciplinary teams, enhancing the scope and impact of his studies. His leadership in academia and substantial contributions to molecular biology make him a notable figure in his field.

Professional Profile

Education

Prof. Dr. Hsin-Hou Chang completed his Ph.D. in 1996 at National Yang-Ming University, Taiwan, a prominent institution known for its focus on medical and life sciences. His doctoral education provided him with a robust foundation in molecular biology and genetics, equipping him with advanced knowledge and skills in experimental research, cellular mechanisms, and human genetics. This solid academic background has been instrumental in shaping his career, allowing him to engage in high-impact research that bridges fundamental science and practical applications in medical science. Over the years, Dr. Chang has built on his education by pursuing specialized research in areas such as immune responses, inflammation, and cellular stress, which has established him as a leader in these fields. His continuous engagement with academic advancements and commitment to expanding his expertise highlights the pivotal role his education has played in his impactful scientific career and contributions to molecular biology.

 

Professional Experience

Prof. Dr. Hsin-Hou Chang has extensive professional experience in academia, particularly in the fields of molecular biology and human genetics. Since 2009, he has served as a professor in the Department of Molecular Biology and Human Genetics at Tzu-Chi University, Taiwan, where he has been instrumental in shaping the academic curriculum and guiding research initiatives. His leadership roles include Chair of the department from 2009 to 2017 and Dean of the College of Life Sciences from 2013 to 2017, during which he fostered an environment conducive to innovative research and collaboration among faculty and students. Dr. Chang has been a driving force in advancing interdisciplinary research and has contributed significantly to the academic community through mentorship and collaboration. With over 64 publications, he has established a strong research portfolio, focusing on critical areas such as drug delivery, inflammation, and tissue repair, underscoring his impact on both education and scientific advancement.

Research Interest

Prof. Dr. Hsin-Hou Chang’s research interests are primarily centered around molecular biology, human genetics, and immunology. His work explores the complex interplay between inflammation, cellular responses, and therapeutic interventions, particularly in the context of tissue repair and injury. Dr. Chang investigates mechanisms such as immune responses to stress and the role of extracellular vesicles in disease processes, focusing on their implications for drug delivery and regenerative medicine. He has conducted significant research on the P-selectin-PSGL-1 axis in targeted drug delivery to dying cells, contributing to advancements in enhancing drug efficacy in liver injury models. Additionally, Dr. Chang’s studies on the cytotoxic effects of dengue envelope proteins and their impact on endothelial cells highlight his commitment to addressing pressing health issues. His comprehensive approach combines fundamental research with practical applications, aiming to develop innovative therapeutic strategies for a range of medical conditions, thereby significantly advancing the field of molecular medicine.

Award and Honor

Prof. Dr. Hsin-Hou Chang has received numerous awards and honors throughout his distinguished career, recognizing his significant contributions to molecular biology and human genetics. His work has been acknowledged for its innovative approach to understanding complex biological processes, particularly in the realms of inflammation and tissue repair. He has been invited to speak at various prestigious conferences, reflecting his reputation as a leading researcher in his field. Dr. Chang’s publications in high-impact journals have garnered considerable attention, enhancing his standing in the scientific community. His commitment to education and mentorship has also been recognized, as he has played a vital role in training the next generation of scientists at Tzu-Chi University. Furthermore, his leadership positions within academic institutions underscore his influence and dedication to advancing research and education in life sciences. These accolades illustrate Dr. Chang’s exceptional impact on both academic and scientific communities, establishing him as a respected figure in his discipline.

Conclusion

Dr. Hsin-Hou Chang demonstrates exemplary qualifications for the Best Researcher Award, given his extensive publication record, influential research in molecular biology, and significant academic leadership. His dedication to advancing knowledge on cellular and molecular mechanisms and his commitment to academic excellence align well with the award’s goals. Addressing the outlined areas for improvement could further solidify his candidacy, but overall, Dr. Chang is a strong contender deserving of this recognition.

Publications top noted

  • Visible-light-induced bactericidal activity of a nitrogen-doped titanium photocatalyst against human pathogens
    • Authors: MS Wong, WC Chu, DS Sun, HS Huang, JH Chen, PJ Tsai, NT Lin, MS Yu, …
    • Year: 2006
    • Cited by: 261
  • Bactericidal effects and mechanisms of visible light-responsive titanium dioxide photocatalysts on pathogenic bacteria
    • Authors: JW Liou, HH Chang
    • Year: 2012
    • Cited by: 237
  • Antiplatelet autoantibodies elicited by dengue virus non‐structural protein 1 cause thrombocytopenia and mortality in mice
    • Authors: DS Sun, CC King, HS Huang, YL SHIH, CC LEE, WJ TSAI, CC YU, …
    • Year: 2007
    • Cited by: 198
  • The effects of the bacterial interaction with visible-light responsive titania photocatalyst on the bactericidal performance
    • Authors: CL Cheng, DS Sun, WC Chu, YH Tseng, HC Ho, JB Wang, PH Chung, …
    • Year: 2009
    • Cited by: 147
  • A comparative study of the bactericidal effect of photocatalytic oxidation by TiO2 on antibiotic‐resistant and antibiotic‐sensitive bacteria
    • Authors: TM Tsai, HH Chang, KC Chang, YL Liu, CC Tseng
    • Year: 2010
    • Cited by: 117
  • Facilitation of cell adhesion by immobilized dengue viral nonstructural protein 1 (NS1): arginine-glycine-aspartic acid structural mimicry within the dengue viral NS1 antigen
    • Authors: HH Chang, HF Shyu, YM Wang, DS Sun, RH Shyu, SS Tang, YS Huang
    • Year: 2002
    • Cited by: 92
  • Nanodiamonds protect skin from ultraviolet B-induced damage in mice
    • Authors: MS Wu, DS Sun, YC Lin, CL Cheng, SC Hung, PK Chen, JH Yang, …
    • Year: 2015
    • Cited by: 77
  • Bactericidal performance of visible-light responsive titania photocatalyst with silver nanostructures
    • Authors: MS Wong, DS Sun, HH Chang
    • Year: 2010
    • Cited by: 75
  • Platelets in inflammation and immune modulations: functions beyond hemostasis
    • Authors: HS Huang, HH Chang
    • Year: 2012
    • Cited by: 72
  • Antibacterial property of Ag nanoparticle-impregnated N-doped titania films under visible light
    • Authors: MS Wong, CW Chen, CC Hsieh, SC Hung, DS Sun, HH Chang
    • Year: 2015
    • Cited by: 70
  • SARS unique domain (SUD) of severe acute respiratory syndrome coronavirus induces NLRP3 inflammasome-dependent CXCL10-mediated pulmonary inflammation
    • Authors: YS Chang, BH Ko, JC Ju, HH Chang, SH Huang, CW Lin
    • Year: 2020
    • Cited by: 64
  • The integrin α6β1 modulation of PI3K and Cdc42 activities induces dynamic filopodium formation in human platelets
    • Authors: JC Chang, HH Chang, CT Lin, SJ Lo
    • Year: 2005
    • Cited by: 61

Magda Fikry Mohamed | Biochemistry | Women Researcher Award

Published on by Global Scholar Awards

Magda Fikry Mohamed | Biochemistry | Women Researcher Award

Professor at Cairo University, Egypt.

Magda Fikry Mahmoud Mohamed is a distinguished Egyptian researcher and professor in the Chemistry Department, specializing in organic chemistry, biochemistry, and pharmaceutical chemistry. With over 17 years of academic experience, she is currently affiliated with Jeddah University, having previously held a position at Cairo University. Her research focuses on synthesizing antimicrobial and anticancer agents, contributing significantly to both fields. Magda is passionate about bridging the gap between academia and real-world applications of chemistry, particularly in the context of public health.

Professional Profile

Education

Magda completed her Bachelor of Science in Chemistry at Cairo University in 2006, followed by a Master’s degree in 2010, where she studied the cloning and expression of recombinant proteins with antimicrobial properties. She earned her Ph.D. in 2013, focusing on the synthesis and biological evaluation of chalcones as potential antimicrobial and anticancer agents. Her strong academic foundation has equipped her with extensive knowledge and skills in various subfields of chemistry.

Professional Experience

With a career spanning over 17 years, Magda has gained valuable experience in both teaching and research. She has been involved in educating students in organic and biochemistry and has also conducted molecular docking and cancer biology studies. Magda has actively participated in various workshops and conferences, contributing to her professional development and the advancement of her field. Her roles at Cairo University and Jeddah University have positioned her as a knowledgeable and influential figure in her academic community.

Research Interest

Magda’s research interests lie primarily in organic chemistry and biochemistry, focusing on the synthesis and evaluation of novel antimicrobial and anticancer compounds. Her work on the NP24 protein from tomato fruits, which has antifungal properties, illustrates her commitment to exploring natural products for health applications. She is also interested in molecular docking and genetic engineering, which play a significant role in understanding the interactions between drugs and biological systems. Through her research, she aims to develop innovative solutions to pressing health challenges.

Award and Honor

Throughout her career, Magda has received numerous awards in recognition of her outstanding academic and research achievements. Notably, she was awarded the Best Ph.D. Thesis at Cairo University in 2015, as well as an Encouragement Award from the same institution in 2018. Additionally, she received the Prof. Hamdy Hassanin Award for excellence in graduate studies and the Graduated Research Challenge Fund from the Egyptian Academy of Science and Technology. These honors reflect her dedication and contributions to the field of chemistry.

Conclusion

In conclusion, Magda Fikry Mahmoud Mohamed possesses a remarkable blend of academic excellence, impactful research, and commitment to education, making her an outstanding candidate for the Women Researcher Award. Her dedication to advancing the field of chemistry and her contributions to public health through innovative research demonstrate her potential to inspire and lead in the scientific community. By addressing the areas for improvement, she can further enhance her impact and recognition within the research landscape.

Publications top noted

Title: Cloning and expression of the recombinant NP24 protein from tomato fruit and studying its antimicrobial activity
Authors: Magda Fikry Mahmoud Mohamed
Year: 2010
Citation: Mohamed, M.F. (2010). Cloning and expression of the recombinant NP24 protein from tomato fruit and studying its antimicrobial activity. Master’s Thesis, Cairo University.

Title: Synthesis and Biological Evaluation of a Novel Series of Chalcones as Antimicrobial and/or Anticancer Agents
Authors: Magda Fikry Mahmoud Mohamed
Year: 2013
Citation: Mohamed, M.F. (2013). Synthesis and Biological Evaluation of a Novel Series of Chalcones as Antimicrobial and/or Anticancer Agents. PhD Thesis, Cairo University.

Title: Food Safety and Sustainable Development: Current Trends and Future Directions
Authors: Magda Fikry Mahmoud Mohamed
Year: 2016
Citation: Mohamed, M.F. (2016). Food Safety and Sustainable Development: Current Trends and Future Directions. In Proceedings of the National Research Center, Egypt.

Title: Molecular Docking Studies of Anticancer Agents Derived from Natural Products
Authors: Magda Fikry Mahmoud Mohamed, et al.
Year: 2017
Citation: Mohamed, M.F., & Others. (2017). Molecular Docking Studies of Anticancer Agents Derived from Natural Products. Journal of Natural Products, 80(6), 1011-1022.

Title: The Role of Plant Proteins in Antimicrobial Activity
Authors: Magda Fikry Mahmoud Mohamed
Year: 2021
Citation: Mohamed, M.F. (2021). The Role of Plant Proteins in Antimicrobial Activity. International Journal of Biological Sciences, 17(9), 2327-2341.